Neuromuscular disease: CRISPR/Cas9 gene-editing platform corrects mutations associated with Duchenne muscular dystrophy.

Heather Wood

Open Access

https://doi.org/10.1038/nrneurol.2015.37

Copy DOI

Journal: Nature reviews. Neurology	Publication Date: Mar 10, 2015
Citations: 2

Abstract

Neuromuscular disease: CRISPR/Cas9 gene-editing platform corrects mutations associated with Duchenne muscular dystrophy

Full Text

Published version (

Free)

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Paper Title

Journal

Date

Author